North America Is Expected To Hold A Dominant Position in the Global Cold Plasma Bio-Welding Device Market

Growing research and development activities in the field of cold plasma bio-welding technology are predominantly fueling the growth of the market. For instance, in September 2019, researchers from the University of Antwerp, Belgium, evaluated the influence of the cell type, cancer type, and cell culture medium on direct and indirect cold atmospheric plasma treatment. Also, in August 2019, researchers from Leibniz Institute for Plasma Science and Technology found that plasma treatment is a safe and promising therapeutic option and that it does not promote metastatic behavior in pancreatic cancer cells in vitro and in ovo.

According to the Trendlines Group, an innovation commercialization company, there are about 5 million skin grafts annually conducted in the EU. Moreover, there are nearly 70 million surgeries conducted annually in the United States requiring incision closures. This is expected to accelerate the growth of the cold plasma bio-welding device market.

Ethicon, Inc., Baxter International, Inc., 3M Company, Covidien PLC, Coloplast A/S, and Smith & Nephew are major players in the market.
Coherent Market Insights celebrating 5th anniversary and offering 1000 USD off for all reports. Let’s celebrate with us.

Click for promo code: https://www.coherentmarketinsights.com/promo/buynow/50

Cold Plasma is a new method for joining thin layers of biological or synthetic material together with plasma gases. The combination of metals and chemicals creates a solid structure that is highly conductive. It is able to induce high temperatures and provide high levels of power. This means that cold plasma technology is used to create a wide range of products, including sheets used for surgery. It has become an important process in the surgical industry for the creation of synthetic and life-support tissues for tissue engineering and other uses. It is now used to generate different-sized sheets through a cold fusion process. The main benefits of using this bio-medical instrument are that it requires less time for the surgeon while performing the surgical operations. It is also capable of providing thicker skin grafts by eliminating the use of more than one surgical steel. This device can be used to create skin grafts and various types of synthetic materials for the betterment of patients with different kinds of diseases.

North America is expected to hold a dominant position in the global cold plasma bio-welding device market over the forecast period owing to increasing product approvals to expand their product portfolio. For instance, in August 2019, the U.S. FDA approved a US Medical Innovations LLC-developed cold atmospheric plasma system ‘Canady Helios Cold Plasma System and Scalpel’ for human clinical trials.

Read more @ https://www.coherentmarketinsights.com/ongoing-insight/cold-plasma-bio-welding-device-market-50

Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com

About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.

This release was published on openPR.